IGF1 and Insulin resistance: Prevailing theory has been that the elevations of circulating IGF-1 and insulin levels in insulin resistance and type 2 diabetes are both partly responsible for the acceleration of VSMC proliferation and restenosis causing stent failure in the treatment for coronary artery disease15,33.